53rd EASD Annual Meeting (2)
Lisbon, Portugal, 11-Sep-17
Industry Symposium Boehringer/Lilly (Part 2): Reducing cardiovascular mortality while considering the kidney in type 2 diabetes: can we do more?
Cosentino, MD, PhD F.
32nd Camillo Golgi Lecture: Recurrent hypoglycemia in diabetes: the long-term complications
Sattar, Prof. Dr. N.
EASD/ESC Symposium: Cardiovascular complications of diabetes: hot topics
Vilsboll, Dr. T.
An emerging and innovative therapeutic approach in type 1 diabetes with dual SGLT1 and SGLT2 inhibition: the Sotagliflozin Clinical Program
Deacon, MD C.F.
Poster Session 99 - Cardiovascular complications: prevalence and treatment initiation
Ceriello, Prof. A.
Supported by Boehringer Ingelheim Pharma GmbH & Co. KG